COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
HCQ news
5/7 N/A
Sermo (News) (not included in the study count)
Sermo reports: COVID-19 treatment trends over 6 weeks and 33,700 interviews: Usage, efficacy and safety perceptions of most-used therapies
Source   PDF   Share   Tweet
HCQ used by 55% of physicians worldwide for COVID. Survey of 6,150 physicians.

Sermo et al., 5/7/2020, preprint, 1 author.
Details of all 260 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit